SCHEMBL11285014

SCHEMBL11285014

O=C(COc1ccccc1)COP(=O)(O)O

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.55
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
GAA P10253 1/20 0.50
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
ALPL P05186 1/20 0.49
ALPI P09923 1/20 0.49
ALPG P10696 1/20 0.49
PLA2G4B P0C869 2/20 0.47
HTT P42858 1/20 0.47
HPGD P15428 1/20 0.47
SRC P12931 1/20 0.47
ALDH1A1 P00352 1/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3898377 0.84 ALOX15 (0.74) ALOX15GAAKMT2AMEN1ALPL
SCHEMBL5071825 0.81 ALOX15 (0.50) ALOX15CYP2C9CYP2C19GAAKMT2A
SCHEMBL571951 0.80 PKM (0.50) ALOX15CYP2C9CYP2C19GAAKMT2A
SCHEMBL1345641 0.80 ALOX15 (0.57) ALOX15CYP2C9CYP2C19GAAKMT2A
SCHEMBL11956755 0.79 ALOX15 (0.65) ALOX15GAAKMT2AMEN1ALPL
SCHEMBL27789509 0.77 CYP2C9 (0.59) ALOX15CYP2C9CYP2C19GAAKMT2A
SCHEMBL15396047 0.77 ALOX15 (0.68) ALOX15GAAKMT2AMEN1ALPL
SCHEMBL24487000 0.76 TSHR (0.48) KMT2AMEN1ALDH1A1
SCHEMBL16383050 0.76 ALOX15 (0.57) ALOX15CYP2C9CYP2C19GAAKMT2A
SCHEMBL28858275 0.76 ALOX15 (0.57) ALOX15CYP2C9CYP2C19GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116947633-A Synthesis method of tafluprost 广州楷石医药有限公司 2023-10-27 CN disclosed
CN-116425707-A Tafluprost intermediate isomer impurity and preparation method thereof 南京华威医药科技集团有限公司 2023-07-14 CN disclosed
EP-0025687-B1 15-METHANESULFONAMIDOPROSTAGLANDIN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THEREOF AND PROCESS THEREFOR PFIZER INC. (US) 1982-11-24 EP disclosed
EP-0025687-A1 15-Methanesulfonamidoprostaglandin derivatives, pharmaceutical compositions thereof and process therefor PFIZER INC. (US) 1981-03-25 EP disclosed